A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Key Points

• The research aims to evaluate a care pathway for treating inflammatory bowel disease and its impact on healthcare costs and cost-effectiveness.
• Conducted as a multicentre study for inflammatory bowel disease treatment.
• Evaluated the impacts on healthcare costs and cost-effectiveness.
• Focused on value-based healthcare improvements.
• The care pathway significantly reduced healthcare costs.
• It was determined to be cost-effective for treating inflammatory bowel disease.
• Improved patient outcomes were noted, enhancing overall value-based healthcare.

Abstract